EUVIMEDEUVIMED entdecken
Crossref

Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis

Adil Uğur Çetin, Ece Ünal Çetin, Özge Kurtkulağı, Murat Daş, Esen Şimşek, Fatih Kamış, Ferhan Demirer Aydemir, Yavuz Beyazıt

Troia Medical Journal · 06.01.2026 · 7 (1) · 10-18

DOI: 10.55665/troiamedj.1830321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Troia Medical Journal, online erschienen am 06.01.2026. Verfasst von Adil Uğur Çetin und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: none.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Sepsis remains a major global health problem with high morbidity and mortality rates, mostly in intensive care unit (ICU) settings. The Pan-Immune Inflammation Value (PIIV), a composite marker derived from neutrophil, monocyte, platelet, and lymphocyte counts, has recently emerged as a potential indicator of systemic inflammation. This study aimed to evaluate the prognostic performance of PIIV and platelet-derived indices, including mean platelet volume (MPV) in predicting 30-day mortality among ICU-admitted sepsis patients.

Methods

This retrospective study included 191 adult patients with sepsis admitted to the ICU of a tertiary care hospi-tal. Laboratory parameters, including PIIV, MPV, PLR, and lactate, along with various clinical and laboratory parame-ters were recorded within the first 24 hours of ICU admission. Logistic regression analysis (LRA) and receiver operat-ing characteristic curve (ROC) analysis were performed to determine predictors of 30-day mortality.

Results

Of the total cohort, 96 patients (50.3%) died within 30 days after ICU admission. PIIV, MPV, and lactate levels were found to be elevated in non-survivors (p=0.001, p=0.003, and p=0.001, respectively). In multivariate LRA, PIIV (OR: 1.235; 95% CI: 1.086–1.404; p=0.001), MPV (OR: 1.346; 95% CI: 1.111–1.630; p=0.002), lactate, and urea were independently associated with mortality. ROC analysis showed that PIIV had an AUROC of 0.643 at a cut-off value of ≥1.2, while MPV had an AUROC of 0.623 at a cut-off of ≥11.5 fL.

Conclusion

Integrating PIIV and MPV into the clinical assessment of sepsis patients may improve decision-making in the management of critically ill septic patients in intensive care units.

Förderung

  • none

Zitieren

APA

Çetin, A. U., Çetin, E. Ü., Kurtkulağı, Ö., Daş, M., Şimşek, E., Kamış, F., Aydemir, F. D., & Beyazıt, Y. (2026). Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis. Troia Medical Journal, 7(1), 10-18. https://doi.org/10.55665/troiamedj.1830321

Vancouver

Çetin AU, Çetin EÜ, Kurtkulağı Ö, Daş M, Şimşek E, Kamış F, et al. Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis. Troia Medical Journal. 2026;7(1):10-18. doi:10.55665/troiamedj.1830321

BibTeX
@article{etin2026,
  author = {Çetin, Adil Uğur and Çetin, Ece Ünal and Kurtkulağı, Özge and Daş, Murat and Şimşek, Esen and Kamış, Fatih and Aydemir, Ferhan Demirer and Beyazıt, Yavuz},
  title = {Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis},
  journal = {Troia Medical Journal},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {10--18},
  doi = {10.55665/troiamedj.1830321}
}
Kostenlos starten →